Unknown

Dataset Information

0

Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats.


ABSTRACT: RATIONALE:GABAA positive allosteric modulators (GABAA PAMs), such as diazepam and zolpidem, are used clinically for anxiety and insomnia, but abuse liability is a concern. Novel GABAA PAMS may have lower abuse liability while retaining clinical utility. OBJECTIVE:The present study compared abuse-related effects of the non-selective GABAA PAM diazepam, the ?1-selective GABAA PAM zolpidem, and three novel GABAA PAMs (JY-XHe-053, XHe-II-053, and HZ-166) using intracranial self-stimulation (ICSS) in rats. These novel compounds have relatively low efficacy at ?1-, ?2-, and ?3-containing GABAA receptors, putative in vivo selectivity at ?2/?3-containing GABAA receptors, and produce anxiolytic-like effects with limited sedation in non-human primates. METHODS:Adult, male Sprague-Dawley rats (n = 17) were each implanted with a bipolar electrode in the medial forebrain bundle and trained to respond under a fixed-ratio 1 schedule of reinforcement for electrical brain stimulation. The potency and time course of effects were compared for diazepam (0.1-10 mg/kg), zolpidem (0.032-3.2 mg/kg), and the three novel compounds (JY-XHe-053, XHe-II-053, and HZ-166; all 3.2-32 mg/kg). RESULTS:Zolpidem and diazepam produced transient facilitation of ICSS at small doses and more sustained rate-decreasing effects at larger doses. JY-XHe-053 and HZ-166 produced weak and inconsistent ICSS facilitation, whereas XHe-II-053 had no effect on ICSS. CONCLUSIONS:These results support a key role for ?1-containing GABAA receptors in mediating GABAA PAM-induced ICSS facilitation. These results are concordant with drug self-administration studies in monkeys in suggesting that GABAA PAMs with low ?1 efficacy and putative ?2/?3 selectivity have lower abuse liability than high-efficacy non-selective or ?1-selective GABAA PAMs.

SUBMITTER: Schwienteck KL 

PROVIDER: S-EPMC5875719 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Abuse-related effects of subtype-selective GABA<sub>A</sub> receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats.

Schwienteck Kathryn L KL   Li Guanguan G   Poe Michael M MM   Cook James M JM   Banks Matthew L ML   Stevens Negus S S  

Psychopharmacology 20170401 14


<h4>Rationale</h4>GABA<sub>A</sub> positive allosteric modulators (GABA<sub>A</sub> PAMs), such as diazepam and zolpidem, are used clinically for anxiety and insomnia, but abuse liability is a concern. Novel GABA<sub>A</sub> PAMS may have lower abuse liability while retaining clinical utility.<h4>Objective</h4>The present study compared abuse-related effects of the non-selective GABA<sub>A</sub> PAM diazepam, the α1-selective GABA<sub>A</sub> PAM zolpidem, and three novel GABA<sub>A</sub> PAMs (  ...[more]

Similar Datasets

| S-EPMC5497587 | biostudies-literature
| S-EPMC8285414 | biostudies-literature
| S-EPMC4873749 | biostudies-literature
| S-EPMC3651663 | biostudies-literature
| S-EPMC5130132 | biostudies-literature
| S-EPMC3263948 | biostudies-literature
| S-EPMC4899155 | biostudies-literature
| S-EPMC4690453 | biostudies-literature
| S-EPMC3369763 | biostudies-other
| S-EPMC7070463 | biostudies-literature